|
"hara h"的相关文件
显示项目 11-15 / 15 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-06-17T03:00:34Z |
Hematopoietic chimerism following allotransplantation of the spleen, splenocytes or kidney in pigs
|
Hara H.;Lin Y.J.;Hao-Chih Tai;Ezzelarab M.;Quader M.A.;Houser S.L.;Nakao A.;Cooper D.K.C.; Hara H.; Lin Y.J.; HAO-CHIH TAI; Ezzelarab M.; Quader M.A.; Houser S.L.; Nakao A.; Cooper D.K.C. |
| 臺大學術典藏 |
2020-05-25T07:35:08Z |
Phase I study results from an esophageal squamous cell carcinoma (ESCC) cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor �] (TGF-�]) and PD-L1
|
Chia-Chi Lin; Doi T; Muro K; Hou M.-M; Esaki T; Hara H; Chung H.-C; Osada M; Helwig C; Kondo S. |
| 國家衛生研究院 |
2019-10 |
Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II
|
Chua, YJ;Pavlakis, N;Sjoquist, KM;Martin, AJ;Tsobanis, E;Yip, S;Bang, YJ;Alcindor, T;O'Callaghan, CJ;Bekaii-Saab, TS;Grothey, A;Chen, LT;Simes, J;Zalcberg, JR;Goldstein, D;Komatsu, Y;Machida, N;Esaki, T;Hara, H;Shitara, K |
| 國家衛生研究院 |
2018-12-19 |
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase 2 trial (AT
|
Boku, N;Ryu, MH;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2017-09 |
Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37)
|
Kang, YK;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Boku, N;Chen, LT |
显示项目 11-15 / 15 (共1页)
1
每页显示[10|25|50]项目
|
